All Stories

  1. Lipoprotein Particle Concentrations in Children and Adults following Kawasaki Disease

    Article • The Journal of Pediatrics, October 2014, Elsevier

    Dr Ray Pourfarzib

  2. Relationship between plasma apolipoprotein B concentrations and LDL particle number

    Article • Research Reports in Clinical Cardiology, September 2014, Taylor & Francis

    Professor Ngoc-Anh N Le, Dr Ray Pourfarzib, Michael D Shapiro

  3. Impact of a Paleolithic Diet on Modifiable Cardiovascular Risk Factors

    Article • Journal of Clinical Lipidology, May 2014, Elsevier

    Dr Ray Pourfarzib

  4. Identifying Insulin Resistant Children Utilizing Lipoprotein-Based Measurements

    Article • Journal of Clinical Lipidology, May 2014, Elsevier

    Dr Ray Pourfarzib

  5. Lipoprotein Measurements in Patients Infected with HIV: Is Cholesterol Content of HDL and LDL Discordant with Particle Number?

    Article • Journal of Clinical Lipidology, May 2014, Elsevier

    Dr Ray Pourfarzib

  6. EFFECTS OF ALIROCUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, ON LIPOPROTEIN PARTICLE CONCENTRATIONS DETERMINED BY NUCLEAR MAGNETIC RESONANCE: SUBSTUDY OF A RANDOMIZED DOUBLE-BLIND PHASE II CLINICAL TRIAL

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Ray Pourfarzib

  7. Heterogeneity of LDL and HDL Particle Concentrations in Subjects Meeting LDL-Cholesterol Goals

    Article • Journal of Clinical Lipidology, May 2013, Elsevier

    Dr Ray Pourfarzib

  8. HDL Particle Number in Patients with Angiographic Coronary Artery Disease on Lipid-Lowering Medication

    Article • Journal of Clinical Lipidology, May 2013, Elsevier

    Dr Ray Pourfarzib

  9. Lipoprotein Particle Number (LDL-P) Distribution in Polycystic Ovary Syndrome Patients

    Article • Journal of Clinical Lipidology, May 2013, Elsevier

    Dr Ray Pourfarzib

  10. Discordance Between LDL Particle Number (LDL-P) and LDL-cholesterol (LDL-C) Among Patients Treated at Two Medical Systems

    Article • Journal of Clinical Lipidology, May 2013, Elsevier

    Dr Ray Pourfarzib

  11. DISCORDANCE IN LOW-DENSITY LIPOPROTEIN PARTICLE NUMBER (LDL-P) AND APOLIPOPROTEIN B (APO B) LEVEL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Ray Pourfarzib

  12. NMR-BASED LIPOPROTEIN PARTICLE PROFILING IDENTIFIES NOVEL SIGNATURES FOR CARDIOVASCULAR DISEASE

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Dr Ray Pourfarzib

  13. Evaluation of Low-Density Lipoprotein Particle Number Distribution in Patients With Type 2 Diabetes Mellitus With Low-Density Lipoprotein Cholesterol <50 mg/dl and Non-High-Density Lipoprotein Cholesterol <80 mg/dl

    Article • The American Journal of Cardiology, September 2012, Elsevier

    Dr Thomas D Dayspring, Dr Ray Pourfarzib

  14. Opportunities for Using Lipoprotein Subclass Profile by Nuclear Magnetic Resonance Spectroscopy in Assessing Insulin Resistance and Diabetes Prediction

    Article • Metabolic Syndrome and Related Disorders, August 2012, Mary Ann Liebert Inc

    Dr Ray Pourfarzib

  15. Heterogeneity of Low-Density Lipoprotein Particle Number at Normal Concentrations of Lipoprotein (a) in Hyperlipidemia Patients

    Article • Journal of Clinical Lipidology, May 2012, Elsevier

    Dr Ray Pourfarzib

  16. Adolescent Diet and Metabolic Syndrome in Young Women: Results of the Dietary Intervention Study in Children (DISC) Follow-Up Study

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2011, Endocrine Society

    Dr Ray Pourfarzib

  17. Clinical utility of low-density lipoprotein particle measurement in management of cardiovascular disease: a case report

    Article • Research Reports in Clinical Cardiology, April 2011, Taylor & Francis

    Dr Ray Pourfarzib

  18. HETEROGENEITY OF LOW-DENSITY LIPOPROTEIN PARTICLE NUMBER (LDL-P) IN TYPE 2 DIABETES AT LOW CONCENTRATIONS OF LDL CHOLESTEROL (LDL-C <50 MG/DL)

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Dr Ray Pourfarzib

  19. Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk

    Article • Atherosclerosis, November 2010, Elsevier

    Dr Ray Pourfarzib

  20. Low-Density Lipoprotein (LDL) Particle Number is Heterogeneous among Persons with and Without Type 2 Diabetes and LDL Cholesterol <100 mg/dL

    Article • Journal of Clinical Lipidology, May 2010, Elsevier

    Dr Ray Pourfarzib

  21. DM1: RANDOMIZED EVALUATION OF A DISEASE MANAGEMENT PROGRAM FOR DYSPEPSIA IN A MANAGED CARE SETTING

    Article • Value in Health, May 1999, Elsevier

    Dr Ray Pourfarzib

  22. Improved Efficacy of a Microencapsulated Macrophage Colony Stimulating Factor and Methotrexate in Melanoma

    Article • Drug Development and Industrial Pharmacy, January 1999, Taylor & Francis

    Dr Ray Pourfarzib